Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 42 min 1 sec ago

U.S. government creates health division for 'religious freedom'

January 18, 2018 - 9:29pm
(Reuters) - The U.S. government will create a division within its health agency that focuses on guaranteeing "conscience and religious freedom" for health workers who say their beliefs prevent them from carrying out abortions and other procedures.

U.S. court invalidates J&J cancer drug patent, hitting UK's BTG

January 18, 2018 - 3:39pm
NEW YORK (Reuters) - A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc .

Toothpaste ingredient could fight malaria, research shows

January 18, 2018 - 3:38pm
LONDON (Reuters) - Research carried out in part by an artificially-intelligent (AI)'robot scientist' has found that a common ingredient of toothpaste could be developed to fight drug-resistant strains of malaria.

India plans to raise health spending by 11 percent in budget; less than requested

January 18, 2018 - 3:05pm
NEW DELHI (Reuters) - India is poised to raise its public health spending by 11 percent in the annual budget next month, after rejecting the health minister's demand for a much bigger increase to ramp up disease control, according to government sources and documents.

Snus tobacco on the rise as Norway smoking halved in a decade

January 18, 2018 - 1:10pm
OSLO (Reuters) - The share of Norwegians who smoke on a daily basis has halved in the last decade and was last year exceeded for the first time by the use of snus, a wet snuff tobacco product, Statistics Norway said on Thursday.

U.S. court invalidates patent on J&J cancer drug Zytiga

January 18, 2018 - 5:28am
NEW YORK (Reuters) - A U.S. administrative court on Wednesday invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions.

Exclusive: Exercise? I get more than people think, Trump says

January 18, 2018 - 4:58am
WASHINGTON (Reuters) - Do not expect U.S. President Donald Trump to hit the gym, despite his doctor's orders.

How neighborhoods shape life with diabetes

January 18, 2018 - 4:03am
(Reuters Health) - - People with diabetes who live in poor communities with limited access to exercise facilities or grocery stores may have a harder time managing their symptoms than diabetics living in more affluent areas, a U.S. study suggests.

Heated abdominal chemo bath improves ovarian cancer survival

January 18, 2018 - 3:40am
(Reuters Health) - - A heated chemotherapy organ bath circulated throughout the abdomen after surgery can significantly prolong a woman's survival with advanced ovarian cancer, according to doctors testing the new treatment.

Senate committee advances Azar nomination as health secretary

January 18, 2018 - 1:57am
WASHINGTON (Reuters) - A U.S. Senate committee on Wednesday voted to move forward the nomination of Alex Azar, a former drug industry executive and lobbyist whom President Donald Trump has tapped to be the next secretary of Health and Human Services.

Brazilians rush to get yellow fever vaccinations amid fatal cases

January 18, 2018 - 1:47am
BRASILIA (Reuters) - Brazilians lined up for hours to get yellow fever vaccinations in Brazil's largest states, alarmed by the increase in the number of fatal cases of infection and a warning from the World Health Organization to tourists visiting parts of the country.

Most states don’t require that kids be checked for health issues

January 18, 2018 - 1:08am
(Reuters Health) - - Most U.S. states don’t require that children be screened for health conditions that can affect learning, according to new research supported by the Children’s Health Fund (CHF).

More evidence common morning sickness drug may not work

January 18, 2018 - 1:01am
(Reuters Health) - - A pill millions of women have used for morning sickness may not actually help relieve nausea, according to a new study that some doctors say reinforces their decision to stop prescribing the drug.

Chart-topping fitness app 'Sweatcoin' secures funding

January 18, 2018 - 12:02am
FRANKFURT (Reuters) - Sweatcoin, a free smartphone app that pays people to be physically active, said on Wednesday it has secured its first round of institutional funding after topping download charts in Britain and the United States.

Physician burnout takes a toll on U.S. patients

January 17, 2018 - 9:19pm
(Reuters Health) - Nearly two-thirds of U.S. doctors feel burned out, depressed, or both – and those feelings affect how they relate to patients, according to a survey conducted by Medscape.

French police search Lactalis sites after baby milk scare

January 17, 2018 - 4:06pm
PARIS (Reuters) - French police were searching several sites belonging to dairy producer Lactalis on Wednesday following a salmonella contamination scare that prompted a global recall of several baby food products, a source at the Paris prosecutor's office said.

Novartis's Kymriah wins speedy reviews in U.S., Europe

January 17, 2018 - 12:48pm
ZURICH (Reuters) - Novartis has been granted fast-track reviews of its cell therapy Kymriah for blood cancers in the United States and Europe, the Swiss drugmaker said on Wednesday, as it seeks to expand the pool of patients eligible for the costly treatment.

Indonesia sends military to help fight health crisis in Papua

January 17, 2018 - 12:15pm
JAKARTA (Reuters) - Indonesia is deploying military paramedics to carry food and vaccines to a remote part of its easternmost province of Papua, where reports say at least 61 infants died from malnutrition and diseases such as measles.

Novartis gets U.S. priority review for Kymriah for adults with lymphoma

January 17, 2018 - 12:00pm
ZURICH (Reuters) - Novartis has been ‍granted priority review for its cell therapy Kymriah for adults with a form of lymphoma by the U.S. Food and Drug Administration, the Swiss drugmaker said on Wednesday, as it seeks to expand use of the treatment in multiple blood cancers.

Wal-Mart launches program to safely dispose of unused opioids

January 17, 2018 - 10:35am
NEW YORK (Reuters) - Wal-Mart Stores Inc on Wednesday said it will provide customers filling prescriptions for opioids with a packet of powder that will help them dispose of leftover medication in order to help curb misuse and abuse.